CONMED Corporation (CNMD) Stock Price
CNMDStock
$46.72+3.91%52W
Market Cap$1.40B
P/E29.74x
PEG Ratio1.84
Div yield0.74%
Beta0.91
CNMD Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)7.69%
Price vs S&P 500 (4W)5.87%
PEG Ratio1.84
VGM Score65.40
P/E Ratio (Annual)29.74x
Indicated Dividend Yield (Annual)0.74%
CNMD Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.11 | $1.38 | +24.33%(+$0.27) | |
| Q1 2026 | $0.82 | $0.89 | +8.79%(+$0.07) | |
| Q4 2025 | $1.32 | $1.43 | +8.04%(+$0.11) | |
| Q3 2025 | $1.05 | $1.08 | +2.65%(+$0.03) | |
| Q2 2025 | $1.12 | $1.15 | +2.39%(+$0.03) |
CNMD Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.55
2.45
2.50
2.50
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
CNMDCONMED Corporation | B | C | B | 1.0x | 9.8% | 55.8% | 8.0% | $46.72 |
| MDTMedtronic plc | B | C | B | 3.2x | 3.8% | 65.7% | 18.1% | $94.75 |
| ITGRInteger Holdings Corporation | C | C | A | 2.3x | 11.6% | 26.1% | 9.7% | $126.70 |
| LIVNLivaNova PLC Ordinary Shares | C | B | B | 2.9x | 8.2% | 68.1% | 12.5% | $77.58 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | 3.7x | 88.2% | 58.7% | 12.2% | $70.78 |
| AXGNAxogen, Inc. Common Stock | F | B | B | 8.1x | 14.9% | 74.6% | -11.8% | $34.62 |
| BLFSBioLife Solutions Inc. | F | C | A | 18.4x | 14.9% | 63.9% | 2.9% | $38.61 |
| CBLLCeriBell, Inc. Common Stock | F | A | A | 9.4x | — | 88.9% | -68.6% | $25.04 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | 2.2x | 12.4% | 76.5% | 18.5% | $14.16 |
| CVCapsoVision, Inc. Common Stock | F | D | B | 25.0x | — | 50.9% | -217.1% | $6.53 |
| ELMDElectromed, Inc. | C | B | C | 3.1x | 15.6% | 78.5% | 18.8% | $27.42 |
About CONMED Corporation
CONMED Corporation is a medical technology company that designs and manufactures surgical devices and equipment for multiple specialties, including orthopedic, general, gynecological, thoracic, and gastroenterological procedures. The company serves surgeons and healthcare professionals globally, with operations spanning North America, Europe, the Middle East, Africa, and Asia-Pacific. The United States represents CONMED's largest market and primary revenue driver.